Paul T. Finger, MD, FACS
Contact information
LOCATION
WEBSITE
http://eyecancer.com
SPECIALTY
Ophthalmic Oncologist
Education and Fellowships
-OTHER
Tulane University
-MEDICAL SCHOOL
Tulane Medical School
-OTHER
Manhattan Eye, Ear and Throat Hospital - Ophthalmology
-FELLOWSHIP
North Shore - Cornell
Current Positions
Director, The New York Eye Cancer Center
Biography
Professor Paul T. Finger, M.D. holds a Lifetime Certification by the American Board of Ophthalmology and is a Fellow of both the American College of Surgeons and the American Academy of Ophthalmology. He is Fellowship-Trained in Ocular Tumor, Orbital Disease and Ophthalmic Radiation Therapy.
Dr. Finger has over 35-years experience in the diagnosis and treatment of cancers in, around and behind the eye. In order to make the diagnosis, Dr. Finger uses the latest diagnostic imaging and ultrasound techniques. In fact, he has researched and developed many of the diagnostic techniques now employed around the world. These include unique applications of: high-frequency anterior segment ultrasound ("ultrasonic biomicroscopy," or UBM), OCT (Optical Coherence Tomography), digital imaging and super small incision aspiration biopsy techniques.
The most common primary intraocular cancer is melanoma. It is often called "choroidal melanoma." Dr. Finger offers the most sophisticated diagnostic and therapeutic options available, including brachytherapy (radioactive material sealed in titanium seeds or orbital catheters placed directly into or near a tumor).
Dr. Finger was the first to use palladium-103 seeds in ophthalmic plaques which has offered better eye and vision compared to iodine-125 or ruthenium-106 (in most cases). Dr. Finger is the first eye cancer specialist to show his near-real-time results his web site http://eyecancer.com. (see https://eyecancer.com/our-approach/doctor-reported-outcomes/)
Dr. Finger believes in excellence through ophthalmic innovation. Never satisfied with less effective methods, he has invented Finger's Slotted Eye Plaques to treat choroidal melanomas that are near, touching or wrapped around the optic nerve and numerous other techniques described on his website http://eyecancer.com.
Dr. Finger has published more than 300 articles, 40 book chapters, two books and performed more than a thousand scientific reviews. He was twice asked to write the eye cancer, choroidal melanoma chapter for the medical oncology textbook "Cancer: Principals and Practice" by Dr. DeVita as well as all the chapters for the International Union Against Cancer (UICC).
However, it was as Chair of the Ophthalmic Oncology Task Force of the American Joint Committee on Cancer (AJCC), that he assembled and coordinated the work of over 50 eye cancer specialists from 18 countries to make universal staging and a common scientific eye cancer language a reality.
LOCATION
- The New York Eye Cancer Center
115 East 61st Street, Suite 5B, New York City, NY 10065
1-212-832-8170 (add 01 for international)
Map and directions »
WEBSITE
http://eyecancer.com
SPECIALTY
Ophthalmic Oncologist
Education and Fellowships
-OTHER
Tulane University
-MEDICAL SCHOOL
Tulane Medical School
-OTHER
Manhattan Eye, Ear and Throat Hospital - Ophthalmology
-FELLOWSHIP
North Shore - Cornell
Current Positions
Director, The New York Eye Cancer Center
Biography
Professor Paul T. Finger, M.D. holds a Lifetime Certification by the American Board of Ophthalmology and is a Fellow of both the American College of Surgeons and the American Academy of Ophthalmology. He is Fellowship-Trained in Ocular Tumor, Orbital Disease and Ophthalmic Radiation Therapy.
Dr. Finger has over 35-years experience in the diagnosis and treatment of cancers in, around and behind the eye. In order to make the diagnosis, Dr. Finger uses the latest diagnostic imaging and ultrasound techniques. In fact, he has researched and developed many of the diagnostic techniques now employed around the world. These include unique applications of: high-frequency anterior segment ultrasound ("ultrasonic biomicroscopy," or UBM), OCT (Optical Coherence Tomography), digital imaging and super small incision aspiration biopsy techniques.
The most common primary intraocular cancer is melanoma. It is often called "choroidal melanoma." Dr. Finger offers the most sophisticated diagnostic and therapeutic options available, including brachytherapy (radioactive material sealed in titanium seeds or orbital catheters placed directly into or near a tumor).
Dr. Finger was the first to use palladium-103 seeds in ophthalmic plaques which has offered better eye and vision compared to iodine-125 or ruthenium-106 (in most cases). Dr. Finger is the first eye cancer specialist to show his near-real-time results his web site http://eyecancer.com. (see https://eyecancer.com/our-approach/doctor-reported-outcomes/)
Dr. Finger believes in excellence through ophthalmic innovation. Never satisfied with less effective methods, he has invented Finger's Slotted Eye Plaques to treat choroidal melanomas that are near, touching or wrapped around the optic nerve and numerous other techniques described on his website http://eyecancer.com.
Dr. Finger has published more than 300 articles, 40 book chapters, two books and performed more than a thousand scientific reviews. He was twice asked to write the eye cancer, choroidal melanoma chapter for the medical oncology textbook "Cancer: Principals and Practice" by Dr. DeVita as well as all the chapters for the International Union Against Cancer (UICC).
However, it was as Chair of the Ophthalmic Oncology Task Force of the American Joint Committee on Cancer (AJCC), that he assembled and coordinated the work of over 50 eye cancer specialists from 18 countries to make universal staging and a common scientific eye cancer language a reality.
Selected publications
- Radiation therapy for choroidal melanoma.
Paul T. Finger, MD Radiotherapy offers patients with malignant melanoma of the choroid an eye and a vision-sparing alternative to enucleation. The most commonly used forms of radiotherapy are ophthalmic plaque brachytherapy and charged-particle (external beam) radiotherapy.The purpose of this review is to present the world's experience with radiotherapy for choroidal melanoma, information that will contribute to patient education and informed consent. - The Finger iridectomy technique: small incision biopsy of anterior segment tumours
Finger PT, Latkany P, Kurli M, Iacob C. The Finger iridectomy technique was a minimally invasive and very effective biopsy technique. Aspiration cutting yielded relatively large pieces of tissue (and cells) used for cytopathological and histopathological evaluation. Small incision surgery allowed for rapid rehabilitation and no significant complications. - Intravitreal anti-VEGF therapy for macular radiation retinopathy: A 10-year Study
Finger PT, Chin KJ, Semenova EA. European Journal of Ophthalmology 2016 Jan-Feb:26(1):60-66. This paper describes Dr. Fingers long-term experience with his technique that suppresses radiation damage and saves vision. - Doctors reported outcomes: Real world data from a tertiary eye cancer center
Maheshwari A, Finger PT, Malpani A, Jain P, Tomar AS, Garg G. Indian J Ophthalmology 2021;69(1):135-139.
